Compositions and methods for the treatment of viral infections
AssigneeDana-Farber Cancer Institute, Inc.
InventorLoren D. Walensky
Life of this patent
Estimating the term…
Loading patent…
AssigneeDana-Farber Cancer Institute, Inc.
InventorLoren D. Walensky
Estimating the term…
The invention provides compositions, kits and methods utilizing polypeptides having a viral alpha-helix heptad repeat domain in a stabilized a-helical structure (herein also referred to as SAH). The compositions are useful for treating and/or preventing viral infections. The invention is based, at least in part, on the result provided herein demonstrating that viral hydrocarbon stapled alpha helical peptides display excellent proteolytic, acid, and thermal stability, restore the native alpha-helical structure of the peptide, are highly effective in interfering with the viral fusogenic process, and possess superior pharmacokinetic properties compared to the corresponding unmodified peptides.
A modified polypeptide comprising a stabilized alpha helix of HIV gp41 heptad repeat domain.
(canceled)
(canceled)
8-9. (canceled)
11-12. (canceled)
14-20. (canceled)
22-24. (canceled)
27-30. (canceled)
32-34. (canceled)
(canceled)
A modified polypeptide comprising a stabilized viral alpha helix heptad repeat-analog domain.
41-51. (canceled)
A modified polypeptide
53-56. (canceled)
59-60. (canceled)
64-79. (canceled)
81-85. (canceled)
Dependencies are inferred from the claim text.